OCX OncoCyte Corporation gains 21% Apr 23, 2018

OncoCyte Corporation, a biotechnology company, operates in the field of regenerative medicine. The company is developing molecular cancer diagnostics using a discovery platform that focuses on identifying genetic markers expressed in various types of cancer. It develops diagnostic tests for use in detecting various cancers, including lung, bladder, and breast cancers. The company was founded in 2009 and is based in Alameda, California. OncoCyte Corporation operates as a subsidiary of BioTime, Inc.http://www.priceseries.com/trade/OCX-OncoCyte-Corporation-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2018040520180423.html